<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32859714</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>40</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the <i>SOD1<sup>G37R</sup></i> ALS Mouse Model.</ArticleTitle><Pagination><StartPage>7759</StartPage><EndPage>7777</EndPage><MedlinePgn>7759-7777</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1523/JNEUROSCI.1748-18.2020</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting motoneurons (MNs) in a motor-unit (MU)-dependent manner. Glial dysfunction contributes to numerous aspects of the disease. At the neuromuscular junction (NMJ), early alterations in perisynaptic Schwann cell (PSC), glial cells at this synapse, may impact their ability to regulate NMJ stability and repair. Indeed, muscarinic receptors (mAChRs) regulate the repair phenotype of PSCs and are overactivated at disease-resistant NMJs [soleus muscle (SOL)] in <i>SOD1<sup>G37R</sup></i> mice. However, it remains unknown whether this is the case at disease-vulnerable NMJs and whether it translates into an impairment of PSC-dependent repair mechanisms. We used SOL and sternomastoid (STM) muscles from <i>SOD1<sup>G37R</sup></i> mice and performed Ca<sup>2+</sup>-imaging to monitor PSC activity and used immunohistochemistry to analyze their repair and phagocytic properties. We show that PSC mAChR-dependent activity was transiently increased at disease-vulnerable NMJs (STM muscle). Furthermore, PSCs from both muscles extended disorganized processes from denervated NMJs and failed to initiate or guide nerve terminal sprouts at disease-vulnerable NMJs, a phenomenon essential for compensatory reinnervation. This was accompanied by a failure of numerous PSCs to upregulate galectin-3 (MAC-2), a marker of glial axonal debris phagocytosis, on NMJ denervation in <i>SOD1</i> mice. Finally, differences in these PSC-dependent NMJ repair mechanisms were MU type dependent, thus reflecting MU vulnerability in ALS. Together, these results reveal that neuron-glia communication is ubiquitously altered at the NMJ in ALS. This appears to prevent PSCs from adopting a repair phenotype, resulting in a maladapted response to denervation at the NMJ in ALS.<b>SIGNIFICANCE STATEMENT</b> Understanding how the complex interplay between neurons and glial cells ultimately lead to the degeneration of motor neurons and loss of motor function is a fundamental question to comprehend amyotrophic lateral sclerosis (ALS). An early and persistent alteration of glial cell activity takes place at the neuromuscular junction (NMJ), the output of motor neurons, but its impact on NMJ repair remains unknown. Here, we reveal that glial cells at disease-vulnerable NMJs often fail to guide compensatory nerve terminal sprouts and to adopt a phagocytic phenotype on denervated NMJs in <i>SOD1<sup>G37R</sup></i> mice. These results show that glial cells at the NMJ elaborate an inappropriate response to NMJ degeneration in a manner that reflects motor-unit (MU) vulnerability and potentially impairs compensatory reinnervation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 the authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martineau</LastName><ForeName>&#xc9;ric</ForeName><Initials>&#xc9;</Initials><Identifier Source="ORCID">0000-0002-5503-0798</Identifier><AffiliationInfo><Affiliation>D&#xe9;partement de Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec H3C 3J7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Groupe de Recherche sur le Syst&#xe8;me Nerveux Central, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec, H3C 1J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbour</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec H3C 3J7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Groupe de Recherche sur le Syst&#xe8;me Nerveux Central, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec, H3C 1J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vall&#xe9;e</LastName><ForeName>Joanne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec H3C 3J7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Groupe de Recherche sur le Syst&#xe8;me Nerveux Central, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec, H3C 1J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robitaille</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-6628-0146</Identifier><AffiliationInfo><Affiliation>D&#xe9;partement de Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec H3C 3J7, Canada richard.robitaille@umontreal.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Groupe de Recherche sur le Syst&#xe8;me Nerveux Central, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec, H3C 1J7, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MOP-111070</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037502">Galectin 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011976">Receptors, Muscarinic</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037502" MajorTopicYN="N">Galectin 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010587" MajorTopicYN="N">Phagocytosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011976" MajorTopicYN="N">Receptors, Muscarinic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012583" MajorTopicYN="N">Schwann Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055366" MajorTopicYN="N">Synaptic Potentials</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">galectin-3</Keyword><Keyword MajorTopicYN="N">muscarinic receptors</Keyword><Keyword MajorTopicYN="N">neuron-glia interactions</Keyword><Keyword MajorTopicYN="N">perisynaptic Schwann cells</Keyword><Keyword MajorTopicYN="N">purinergic receptors</Keyword><Keyword MajorTopicYN="N">sprouting</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32859714</ArticleId><ArticleId IdType="pmc">PMC7531543</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.1748-18.2020</ArticleId><ArticleId IdType="pii">JNEUROSCI.1748-18.2020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arbour D, Tremblay E, Martineau E, Julien JP, Robitaille R (2015) Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model. J Neurosci 35:688&#x2013;706. 10.1523/JNEUROSCI.1379-14.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1379-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605374</ArticleId><ArticleId IdType="pubmed">25589763</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour D, Vande Velde C, Robitaille R (2017) New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction. J Physiol 595:647&#x2013;661. 10.1113/JP270213</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP270213</ArticleId><ArticleId IdType="pmc">PMC5285712</ArticleId><ArticleId IdType="pubmed">27633977</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong GA, Drapeau P (2013a) Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS. Hum Mol Genet 22:4282&#x2013;4292. 10.1093/hmg/ddt278</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt278</ArticleId><ArticleId IdType="pubmed">23771027</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong GA, Drapeau P (2013b) Calcium channel agonists protect against neuromuscular dysfunction in a genetic model of TDP-43 mutation in ALS. J Neurosci 33:1741&#x2013;1752. 10.1523/JNEUROSCI.4003-12.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4003-12.2013</ArticleId><ArticleId IdType="pmc">PMC6618732</ArticleId><ArticleId IdType="pubmed">23345247</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkin JD, Scott RL, West JM, Lopes E, Quah AK, Cheema SS (2005) Properties of slow- and fast-twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis. Neuromuscul Disord 15:377&#x2013;388. 10.1016/j.nmd.2005.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2005.02.005</ArticleId><ArticleId IdType="pubmed">15833433</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker DJ, Blackburn DJ, Keatinge M, Sokhi D, Viskaitis P, Heath PR, Ferraiuolo L, Kirby J, Shaw PJ (2015) Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis. Front Cell Neurosci 9:410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4606544</ArticleId><ArticleId IdType="pubmed">26528138</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;lair EL, Vall&#xe9;e J, Robitaille R (2010) In vivo long-term synaptic plasticity of glial cells. J Physiol 588:1039&#x2013;1056. 10.1113/jphysiol.2009.178988</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2009.178988</ArticleId><ArticleId IdType="pmc">PMC2852994</ArticleId><ArticleId IdType="pubmed">20142269</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Vande Velde C, Cleveland DW (2006a) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39&#x2013;59. 10.1016/j.neuron.2006.09.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW (2006b) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312:1389&#x2013;1392. 10.1126/science.1123511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Brichta AM, Callister RJ, Peterson EH (1987) Quantitative analysis of cervical musculature in rats: histochemical composition and motor pool organization. I. Muscles of the spinal accessory complex. J Comp Neurol 255:351&#x2013;368. 10.1002/cne.902550304</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.902550304</ArticleId><ArticleId IdType="pubmed">2950139</ArticleId></ArticleIdList></Reference><Reference><Citation>Brill MS, Lichtman JW, Thompson W, Zuo Y, Misgeld T (2011) Spatial constraints dictate glial territories at murine neuromuscular junctions. J Cell Biol 195:293&#x2013;305. 10.1083/jcb.201108005</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201108005</ArticleId><ArticleId IdType="pmc">PMC3198169</ArticleId><ArticleId IdType="pubmed">22006952</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosius Lutz A, Chung WS, Sloan SA, Carson GA, Zhou L, Lovelett E, Posada S, Zuchero JB, Barres BA (2017) Schwann cells use TAM receptor-mediated phagocytosis in addition to autophagy to clear myelin in a mouse model of nerve injury. Proc Natl Acad Sci USA 114:E8072&#x2013;E8080. 10.1073/pnas.1710566114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710566114</ArticleId><ArticleId IdType="pmc">PMC5617301</ArticleId><ArticleId IdType="pubmed">28874532</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco DI, Seburn KL, Pinter MJ (2016a) Altered terminal Schwann cell morphology precedes denervation in SOD1 mice. Exp Neurol 275:172&#x2013;181. 10.1016/j.expneurol.2015.09.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.014</ArticleId><ArticleId IdType="pmc">PMC4768763</ArticleId><ArticleId IdType="pubmed">26416261</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco DI, Bahr BA, Seburn KL, Pinter MJ (2016b) Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease. Exp Neurol 278:116&#x2013;126. 10.1016/j.expneurol.2016.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.02.002</ArticleId><ArticleId IdType="pmc">PMC4788963</ArticleId><ArticleId IdType="pubmed">26853136</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro R, Taetzsch T, Vaughan SK, Godbe K, Chappell J, Settlage R, Valdez G (2020) Identification of a molecular fingerprint for synaptic glia. eLife 9:e56935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316509</ArticleId><ArticleId IdType="pubmed">32584256</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawley MJ. (2007) The R book. Chichester; Hobokens: Wiley.</Citation></Reference><Reference><Citation>Cunningham ME, Meehan GR, Robinson S, Yao D, McGonigal R, Willison HJ (2020) Perisynaptic Schwann cells phagocytose nerve terminal debris in a mouse model of Guillain-Barr&#xe9; syndrome. J Peripher Nerv Syst 25:143&#x2013;151. 10.1111/jns.12373</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12373</ArticleId><ArticleId IdType="pubmed">32250537</ArticleId></ArticleIdList></Reference><Reference><Citation>Darabid H, Arbour D, Robitaille R (2013) Glial cells decipher synaptic competition at the mammalian neuromuscular junction. J Neurosci 33:1297&#x2013;1313. 10.1523/JNEUROSCI.2935-12.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2935-12.2013</ArticleId><ArticleId IdType="pmc">PMC6618718</ArticleId><ArticleId IdType="pubmed">23345206</ArticleId></ArticleIdList></Reference><Reference><Citation>De Winter F, Vo T, Stam FJ, Wisman LA, B&#xe4;r PR, Niclou SP, van Muiswinkel FL, Verhaagen J (2006) The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol Cell Neurosci 32:102&#x2013;117. 10.1016/j.mcn.2006.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2006.03.002</ArticleId><ArticleId IdType="pubmed">16677822</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditsworth D, Maldonado M, McAlonis-Downes M, Sun S, Seelman A, Drenner K, Arnold E, Ling SC, Pizzo D, Ravits J, Cleveland DW, Da Cruz S (2017) Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis. Acta Neuropathol 133:907&#x2013;922. 10.1007/s00401-017-1698-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1698-6</ArticleId><ArticleId IdType="pmc">PMC5427168</ArticleId><ArticleId IdType="pubmed">28357566</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumic J, Dabelic S, Fl&#xf6;gel M (2006) Galectin-3: an open-ended story. Biochim Biophys Acta 1760:616&#x2013;635. 10.1016/j.bbagen.2005.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2005.12.020</ArticleId><ArticleId IdType="pubmed">16478649</ArticleId></ArticleIdList></Reference><Reference><Citation>Duregotti E, Negro S, Scorzeto M, Zornetta I, Dickinson BC, Chang CJ, Montecucco C, Rigoni M (2015) Mitochondrial alarmins released by degenerating motor axon terminals activate perisynaptic Schwann cells. Proc Natl Acad Sci USA 112:E497&#x2013;E505. 10.1073/pnas.1417108112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1417108112</ArticleId><ArticleId IdType="pmc">PMC4321248</ArticleId><ArticleId IdType="pubmed">25605902</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Kiernan M, Mitsumoto H, Swash M (2014) Amyotrophic lateral sclerosis: a long preclinical period? J Neurol Neurosurg Psychiatry 85:1232&#x2013;1238. 10.1136/jnnp-2013-307135</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307135</ArticleId><ArticleId IdType="pubmed">24648037</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28:41&#x2013;51. 10.1016/S0896-6273(00)00084-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)00084-2</ArticleId><ArticleId IdType="pubmed">11086982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Heath PR, Holden H, Kasher P, Kirby J, Shaw PJ (2007) Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J Neurosci 27:9201&#x2013;9219. 10.1523/JNEUROSCI.1470-07.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1470-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672214</ArticleId><ArticleId IdType="pubmed">17715356</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD (2004) Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185:232&#x2013;240. 10.1016/j.expneurol.2003.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P (2000) Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20:2534&#x2013;2542. 10.1523/JNEUROSCI.20-07-02534.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiou J, Robitaille R, Trimble WS, Charlton MP (1994) Synaptic regulation of glial protein expression in vivo. Neuron 12:443&#x2013;455. 10.1016/0896-6273(94)90284-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(94)90284-4</ArticleId><ArticleId IdType="pubmed">7906531</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiou J, Robitaille R, Charlton MP (1999) Muscarinic control of cytoskeleton in perisynaptic glia. J Neurosci 19:3836&#x2013;3846. 10.1523/JNEUROSCI.19-10-03836.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-10-03836.1999</ArticleId><ArticleId IdType="pmc">PMC6782737</ArticleId><ArticleId IdType="pubmed">10234016</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez de Aguilar JL, Niederhauser-Wiederkehr C, Halter B, De Tapia M, Di Scala F, Demougin P, Dupuis L, Primig M, Meininger V, Loeffler JP (2008) Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol Genomics 32:207&#x2013;218. 10.1152/physiolgenomics.00017.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00017.2007</ArticleId><ArticleId IdType="pubmed">18000159</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, Song S, Likhite S, Murtha MJ, Foust KD, Rao M, Eagle A, Kammesheidt A, Christensen A, Mendell JR, Burghes AH, Kaspar BK (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29:824&#x2013;828. 10.1038/nbt.1957</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T (2007) Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 28:154&#x2013;164. 10.1016/j.nbd.2007.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.07.003</ArticleId><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Tyreman N, Gordon T (2008) Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol 586:3337&#x2013;3351. 10.1113/jphysiol.2007.149286</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2007.149286</ArticleId><ArticleId IdType="pmc">PMC2538809</ArticleId><ArticleId IdType="pubmed">18467368</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, Pitzer C, Dittgen T, Klugmann M, Dupuis L, Schneider A (2011) CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit. Mol Ther 19:284&#x2013;292. 10.1038/mt.2010.271</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2010.271</ArticleId><ArticleId IdType="pmc">PMC3034860</ArticleId><ArticleId IdType="pubmed">21139572</ArticleId></ArticleIdList></Reference><Reference><Citation>Heredia DJ, Feng CY, Hennig GW, Renden RB, Gould TW (2018) Activity-induced Ca(2+) signaling in perisynaptic Schwann cells of the early postnatal mouse is mediated by P2Y1 receptors and regulates muscle fatigue. Elife 7:e30839 10.7554/eLife.30839</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.30839</ArticleId><ArticleId IdType="pmc">PMC5798932</ArticleId><ArticleId IdType="pubmed">29384476</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H, Polymenidou M, Cleveland DW (2009) Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 187:761&#x2013;772. 10.1083/jcb.200908164</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahromi BS, Robitaille R, Charlton MP (1992) Transmitter release increases intracellular calcium in perisynaptic Schwann cells in situ. Neuron 8:1069&#x2013;1077. 10.1016/0896-6273(92)90128-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(92)90128-z</ArticleId><ArticleId IdType="pubmed">1351731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H, Lichtman JW (2013) Motor axon regeneration and muscle reinnervation in young adult and aged animals. J Neurosci 33:19480&#x2013;19491. 10.1523/JNEUROSCI.4067-13.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4067-13.2013</ArticleId><ArticleId IdType="pmc">PMC6618761</ArticleId><ArticleId IdType="pubmed">24336714</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H, Tian L, Mikesh M, Lichtman JW, Thompson WJ (2014) Terminal Schwann cells participate in neuromuscular synapse remodeling during reinnervation following nerve injury. J Neurosci 34:6323&#x2013;6333. 10.1523/JNEUROSCI.4673-13.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4673-13.2014</ArticleId><ArticleId IdType="pmc">PMC4004816</ArticleId><ArticleId IdType="pubmed">24790203</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, Rothstein JD, Bergles DE (2013) Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci 16:571&#x2013;579. 10.1038/nn.3357</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3357</ArticleId><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko CP, Robitaille R (2015) Perisynaptic Schwann cells at the neuromuscular synapse: adaptable, multitasking glial cells. Cold Spring Harb Perspect Biol 7:a020503. 10.1101/cshperspect.a020503</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020503</ArticleId><ArticleId IdType="pmc">PMC4588062</ArticleId><ArticleId IdType="pubmed">26430218</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalancette-H&#xe9;bert M, Swarup V, Beaulieu JM, Bohacek I, Abdelhamid E, Weng YC, Sato S, Kriz J (2012) Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. J Neurosci 32:10383&#x2013;10395. 10.1523/JNEUROSCI.1498-12.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1498-12.2012</ArticleId><ArticleId IdType="pmc">PMC6703730</ArticleId><ArticleId IdType="pubmed">22836271</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerman BJ, Hoffman EP, Sutherland ML, Bouri K, Hsu DK, Liu FT, Rothstein JD, Knoblach SM (2012) Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Brain Behav 2:563&#x2013;575. 10.1002/brb3.75</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.75</ArticleId><ArticleId IdType="pmc">PMC3489809</ArticleId><ArticleId IdType="pubmed">23139902</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobsiger CS, Boillee S, McAlonis-Downes M, Khan AM, Feltri ML, Yamanaka K, Cleveland DW (2009) Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc Natl Acad Sci USA 106:4465&#x2013;4470. 10.1073/pnas.0813339106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0813339106</ArticleId><ArticleId IdType="pmc">PMC2657393</ArticleId><ArticleId IdType="pubmed">19251638</ArticleId></ArticleIdList></Reference><Reference><Citation>Love FM, Thompson WJ (1999) Glial cells promote muscle reinnervation by responding to activity-dependent postsynaptic signals. J Neurosci 19:10390&#x2013;10396. 10.1523/JNEUROSCI.19-23-10390.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-23-10390.1999</ArticleId><ArticleId IdType="pmc">PMC6782417</ArticleId><ArticleId IdType="pubmed">10575036</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas CA, Kang LH, Hoh JF (2000) Monospecific antibodies against the three mammalian fast limb myosin heavy chains. Biochem Biophys Res Commun 272:303&#x2013;308. 10.1006/bbrc.2000.2768</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2000.2768</ArticleId><ArticleId IdType="pubmed">10872844</ArticleId></ArticleIdList></Reference><Reference><Citation>Magill CK, Tong A, Kawamura D, Hayashi A, Hunter DA, Parsadanian A, Mackinnon SE, Myckatyn TM (2007) Reinnervation of the tibialis anterior following sciatic nerve crush injury: a confocal microscopic study in transgenic mice. Exp Neurol 207:64&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2000860</ArticleId><ArticleId IdType="pubmed">17628540</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau E, Di Polo A, Vande Velde C, Robitaille R (2018) Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS. Elife 7:e41973 10.7554/eLife.41973</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.41973</ArticleId><ArticleId IdType="pmc">PMC6234026</ArticleId><ArticleId IdType="pubmed">30320556</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesnard NA, Haulcomb MM, Tanzer L, Sanders VM, Jones KJ (2013) Delayed functional recovery in presymptomatic mSOD1 mice following facial nerve crush axotomy. J Neurodegener Regen 4:21&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3963697</ArticleId><ArticleId IdType="pubmed">24672589</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K, Ferraiuolo L, Miranda CJ, Likhite S, McElroy S, Renusch S, Ditsworth D, Lagier-Tourenne C, Smith RA, Ravits J, Burghes AH, Shaw PJ, Cleveland DW, Kolb SJ, Kaspar BK (2014) Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci USA 111:829&#x2013;832. 10.1073/pnas.1314085111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314085111</ArticleId><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Morizawa YM, Hirayama Y, Ohno N, Shibata S, Shigetomi E, Sui Y, Nabekura J, Sato K, Okajima F, Takebayashi H, Okano H, Koizumi S (2017) Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway. Nat Commun 8:28. 10.1038/s41467-017-00037-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00037-1</ArticleId><ArticleId IdType="pmc">PMC5481424</ArticleId><ArticleId IdType="pubmed">28642575</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen JV, Soto I, Kim KY, Bushong EA, Oglesby E, Valiente-Soriano FJ, Yang Z, Davis CH, Bedont JL, Son JL, Wei JO, Buchman VL, Zack DJ, Vidal-Sanz M, Ellisman MH, Marsh-Armstrong N (2011) Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma. Proc Natl Acad Sci USA 108:1176&#x2013;1181. 10.1073/pnas.1013965108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1013965108</ArticleId><ArticleId IdType="pmc">PMC3024691</ArticleId><ArticleId IdType="pubmed">21199938</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Malley JP, Waran MT, Balice-Gordon RJ (1999) In vivo observations of terminal Schwann cells at normal, denervated, and reinnervated mouse neuromuscular junctions. J Neurobiol 38:270&#x2013;286. 10.1002/(SICI)1097-4695(19990205)38:2&lt;270::AID-NEU9&gt;3.0.CO;2-F</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4695(19990205)38:2&lt;270::AID-NEU9&gt;3.0.CO;2-F</ArticleId><ArticleId IdType="pubmed">10022572</ArticleId></ArticleIdList></Reference><Reference><Citation>Painter MW, Brosius Lutz A, Cheng YC, Latremoliere A, Duong K, Miller CM, Posada S, Cobos EJ, Zhang AX, Wagers AJ, Havton LA, Barres B, Omura T, Woolf CJ (2014) Diminished Schwann cell repair responses underlie age-associated impaired axonal regeneration. Neuron 83:331&#x2013;343. 10.1016/j.neuron.2014.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.06.016</ArticleId><ArticleId IdType="pmc">PMC4106408</ArticleId><ArticleId IdType="pubmed">25033179</ArticleId></ArticleIdList></Reference><Reference><Citation>Parone PA, Da Cruz S, Han JS, McAlonis-Downes M, Vetto AP, Lee SK, Tseng E, Cleveland DW (2013) Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. J Neurosci 33:4657&#x2013;4671. 10.1523/JNEUROSCI.1119-12.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1119-12.2013</ArticleId><ArticleId IdType="pmc">PMC3711648</ArticleId><ArticleId IdType="pubmed">23486940</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, Xu L, Caroni P (2006) Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 9:408&#x2013;419. 10.1038/nn1653</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichert F, Saada A, Rotshenker S (1994) Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2. J Neurosci 14:3231&#x2013;3245. 10.1523/JNEUROSCI.14-05-03231.1994</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.14-05-03231.1994</ArticleId><ArticleId IdType="pmc">PMC6577489</ArticleId><ArticleId IdType="pubmed">8182468</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds ML, Woolf CJ (1992) Terminal Schwann cells elaborate extensive processes following denervation of the motor endplate. J Neurocytol 21:50&#x2013;66. 10.1007/BF01206897</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01206897</ArticleId><ArticleId IdType="pubmed">1346630</ArticleId></ArticleIdList></Reference><Reference><Citation>Robitaille R. (1998) Modulation of synaptic efficacy and synaptic depression by glial cells at the frog neuromuscular junction. Neuron 21:847&#x2013;855. 10.1016/s0896-6273(00)80600-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(00)80600-5</ArticleId><ArticleId IdType="pubmed">9808470</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha MC, Pousinha PA, Correia AM, Sebasti&#xe3;o AM, Ribeiro JA (2013) Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. PLoS One 8:e73846. 10.1371/journal.pone.0073846</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073846</ArticleId><ArticleId IdType="pmc">PMC3764017</ArticleId><ArticleId IdType="pubmed">24040091</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochon D, Rousse I, Robitaille R (2001) Synapse-glia interactions at the mammalian neuromuscular junction. J Neurosci 21:3819&#x2013;3829. 10.1523/JNEUROSCI.21-11-03819.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-11-03819.2001</ArticleId><ArticleId IdType="pmc">PMC6762689</ArticleId><ArticleId IdType="pubmed">11356870</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotshenker S. (2009) The role of galectin-3/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease. J Mol Neurosci 39:99&#x2013;103. 10.1007/s12031-009-9186-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-009-9186-7</ArticleId><ArticleId IdType="pubmed">19253007</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotshenker S. (2011) Wallerian degeneration: the innate-immune response to traumatic nerve injury. J Neuroinflammation 8:109. 10.1186/1742-2094-8-109</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-109</ArticleId><ArticleId IdType="pmc">PMC3179447</ArticleId><ArticleId IdType="pubmed">21878125</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotshenker S, Reichert F, Gitik M, Haklai R, Elad-Sfadia G, Kloog Y (2008) Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia. Glia 56:1607&#x2013;1613. 10.1002/glia.20713</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20713</ArticleId><ArticleId IdType="pubmed">18615637</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousse I, St-Amour A, Darabid H, Robitaille R (2010) Synapse-glia interactions are governed by synaptic and intrinsic glial properties. Neuroscience 167:621&#x2013;632. 10.1016/j.neuroscience.2010.02.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.02.036</ArticleId><ArticleId IdType="pubmed">20188148</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer AM, Sanes JR, Lichtman JW (2005) A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J Comp Neurol 490:209&#x2013;219. 10.1002/cne.20620</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.20620</ArticleId><ArticleId IdType="pubmed">16082680</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino S, Gorza L, Sartore S, Saggin L, Ausoni S, Vianello M, Gundersen K, L&#xf8;mo T (1989) Three myosin heavy chain isoforms in type 2 skeletal muscle fibres. J Muscle Res Cell Motil 10:197&#x2013;205. 10.1007/BF01739810</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01739810</ArticleId><ArticleId IdType="pubmed">2547831</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahidullah M, Le Marchand SJ, Fei H, Zhang J, Pandey UB, Dalva MB, Pasinelli P, Levitan IB (2013) Defects in synapse structure and function precede motor neuron degeneration in Drosophila models of FUS-related ALS. J Neurosci 33:19590&#x2013;19598. 10.1523/JNEUROSCI.3396-13.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3396-13.2013</ArticleId><ArticleId IdType="pmc">PMC3858628</ArticleId><ArticleId IdType="pubmed">24336723</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp PS, Dick JR, Greensmith L (2005) The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neuroscience 130:897&#x2013;910. 10.1016/j.neuroscience.2004.09.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2004.09.069</ArticleId><ArticleId IdType="pubmed">15652988</ArticleId></ArticleIdList></Reference><Reference><Citation>Son YJ, Thompson WJ (1995a) Schwann cell processes guide regeneration of peripheral axons. Neuron 14:125&#x2013;132. 10.1016/0896-6273(95)90246-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90246-5</ArticleId><ArticleId IdType="pubmed">7826630</ArticleId></ArticleIdList></Reference><Reference><Citation>Son YJ, Thompson WJ (1995b) Nerve sprouting in muscle is induced and guided by processes extended by Schwann cells. Neuron 14:133&#x2013;141. 10.1016/0896-6273(95)90247-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90247-3</ArticleId><ArticleId IdType="pubmed">7826631</ArticleId></ArticleIdList></Reference><Reference><Citation>Son YJ, Trachtenberg JT, Thompson WJ (1996) Schwann cells induce and guide sprouting and reinnervation of neuromuscular junctions. Trends Neurosci 19:280&#x2013;285. 10.1016/S0166-2236(96)10032-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-2236(96)10032-1</ArticleId><ArticleId IdType="pubmed">8799973</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Audet JN, Phaneuf D, Kriz J, Julien JP (2012) Abnormal regenerative responses and impaired axonal outgrowth after nerve crush in TDP-43 transgenic mouse models of amyotrophic lateral sclerosis. J Neurosci 32:18186&#x2013;18195. 10.1523/JNEUROSCI.2267-12.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2267-12.2012</ArticleId><ArticleId IdType="pmc">PMC6621743</ArticleId><ArticleId IdType="pubmed">23238732</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallon C, Russell KA, Sakhalkar S, Andrapallayal N, Farah MH (2016) Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice. Neuroscience 312:179&#x2013;189. 10.1016/j.neuroscience.2015.11.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.11.018</ArticleId><ArticleId IdType="pmc">PMC4691388</ArticleId><ArticleId IdType="pubmed">26592719</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson W, Jansen JK (1977) The extent of sprouting of remaining motor units in partly denervated immature and adult rat soleus muscle. Neuroscience 2:523&#x2013;535. 10.1016/0306-4522(77)90049-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(77)90049-5</ArticleId><ArticleId IdType="pubmed">917280</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd KJ, Darabid H, Robitaille R (2010) Perisynaptic glia discriminate patterns of motor nerve activity and influence plasticity at the neuromuscular junction. J Neurosci 30:11870&#x2013;11882. 10.1523/JNEUROSCI.3165-10.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3165-10.2010</ArticleId><ArticleId IdType="pmc">PMC6633406</ArticleId><ArticleId IdType="pubmed">20810906</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay E, Martineau E, Robitaille R (2017) Opposite synaptic alterations at the neuromuscular junction in an ALS mouse model: when motor units matter. J Neurosci 37:8901&#x2013;8918. 10.1523/JNEUROSCI.3090-16.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3090-16.2017</ArticleId><ArticleId IdType="pmc">PMC6596800</ArticleId><ArticleId IdType="pubmed">28821658</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, Ackerley S, Davies KE, Talbot K (2010) Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice. Hum Mol Genet 19:815&#x2013;824. 10.1093/hmg/ddp550</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp550</ArticleId><ArticleId IdType="pubmed">20008901</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez G, Tapia JC, Lichtman JW, Fox MA, Sanes JR (2012) Shared resistance to aging and ALS in neuromuscular junctions of specific muscles. PLoS One 7:e34640. 10.1371/journal.pone.0034640</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034640</ArticleId><ArticleId IdType="pmc">PMC3317643</ArticleId><ArticleId IdType="pubmed">22485182</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dyke JM, Smit-Oistad IM, Macrander C, Krakora D, Meyer MG, Suzuki M (2016) Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS). Exp Neurol 277:275&#x2013;282. 10.1016/j.expneurol.2016.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.01.008</ArticleId><ArticleId IdType="pmc">PMC4762214</ArticleId><ArticleId IdType="pubmed">26775178</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Pytel P, Feltri ML, Wrabetz L, Roos RP (2012) Selective knockdown of mutant SOD1 in Schwann cells ameliorates disease in G85R mutant SOD1 transgenic mice. Neurobiol Dis 48:52&#x2013;57. 10.1016/j.nbd.2012.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.05.014</ArticleId><ArticleId IdType="pubmed">22668777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright MC, Potluri S, Wang X, Dentcheva E, Gautam D, Tessler A, Wess J, Rich MM, Son YJ (2009) Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses. J Neurosci 29:14942&#x2013;14955. 10.1523/JNEUROSCI.2276-09.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2276-09.2009</ArticleId><ArticleId IdType="pmc">PMC2822401</ArticleId><ArticleId IdType="pubmed">19940190</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyatt RM, Balice-Gordon RJ (2008) Heterogeneity in synaptic vesicle release at neuromuscular synapses of mice expressing synaptopHluorin. J Neurosci 28:325&#x2013;335. 10.1523/JNEUROSCI.3544-07.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3544-07.2008</ArticleId><ArticleId IdType="pmc">PMC6671144</ArticleId><ArticleId IdType="pubmed">18171949</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11:251&#x2013;253. 10.1038/nn2047</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang RY, Rabinovich GA, Liu FT (2008) Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 10:e17. 10.1017/S1462399408000719</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1462399408000719</ArticleId><ArticleId IdType="pubmed">18549522</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou JY, Afjehi-Sadat L, Asress S, Duong DM, Cudkowicz M, Glass JD, Peng J (2010) Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach. J Proteome Res 9:5133&#x2013;5141. 10.1021/pr100409r</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr100409r</ArticleId><ArticleId IdType="pmc">PMC2948604</ArticleId><ArticleId IdType="pubmed">20698585</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwiegers P, Lee G, Shaw CA (2014) Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: implications for the assessment of putative therapeutic agents. J Negat Results Biomed 13:14. 10.1186/1477-5751-13-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-5751-13-14</ArticleId><ArticleId IdType="pmc">PMC4134475</ArticleId><ArticleId IdType="pubmed">25103619</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>